Search Options Stock News and Analysis from Schaeffer's

Bulls Blast Viking Therapeutics Stock on Trial Data

https://www.schaeffersresearch.com/content/news/2023/05/16/bulls-blast-viking-therapeutics-stock-on-trial-data

5/16/2023 10:24 AM

Viking Therapeutics Inc (NASDAQ:VKTX) today announced a win for its experimental drug to treat patients with a type of fatty liver disease called non-alcoholic steatohepatitis (NASH). The treatment m...

Biotech Stock Surges to 4-Year Highs on Upbeat Trial

https://www.schaeffersresearch.com/content/news/2023/03/28/biotech-stock-surges-to-4-year-highs-on-upbeat-trial

3/28/2023 10:12 AM

Viking Therapeutics Inc (NASDAQ:VKTX) is surging, last seen up 53.7% at $14.02, after the company revealed plans to start a mid-stage trial for experimental obesity drug VK2735 later this year. This f...

Pharma Stock Gaps Higher After NASH Drug Results

https://www.schaeffersresearch.com/content/news/2019/04/11/pharma-stock-gaps-higher-after-nash-drug-results

4/11/2019 9:50 AM

The shares of Viking Therapeutics Inc (NASDAQ:VKTX) are up 7.5% to trade at $10.89 this morning after the pharma company's non-alcoholic fatty liver disease (NASH) drug met the main goals for its mid-...

Options Volume Hot On Newly Upgraded Drug Stock

https://www.schaeffersresearch.com/content/options/2018/11/19/options-volume-hot-on-newly-upgraded-drug-stock

11/19/2018 2:04 PM

The shares of Viking Therapeutics Inc (NASDAQ:VKTX) are up 1.8% to trade at $11.86, getting a boost from Raymond James, who upgraded the biotech name to "strong buy" from "outperform. The analyst in ...

VKTX, EYEG Stocks Rally on Drug Updates

https://www.schaeffersresearch.com/content/news/2018/11/13/vktx-eyeg-stocks-rally-on-drug-updates

11/13/2018 9:10 AM

Viking Therapeutics Inc (NASDAQ:VKTX) is set to jump 18.5% at the open thanks to news the company's non-alcoholic fatty liver disease treatment met its main and secondary goals in a mid-stage study. ...

PEOPLE ALSO SEARCH FOR